Everett Harris & CO Amgen Inc Transaction History

Everett Harris & CO

$8 Billion
Q3 2024

A detailed history of Everett Harris & CO transactions in Amgen Inc stock. As of the latest transaction made, Everett Harris & CO holds 23,688 shares of AMGN stock, worth $6.24 Million. This represents 0.1% of its overall portfolio holdings.

Number of Shares

23,688

Previous 22,379 5.85%

Holding current value

$6.24 Million

Previous $6.99 Million 9.15%

% of portfolio

0.1%

Previous 0.09%

28 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 18, 2024	BUY	$309.38 - $337.38 $404,978 - $441,630	1,309 Added 5.85%	23,688 $7.63 Million
Q2 2024 Aug 01, 2024	SELL	$262.75 - $319.31 $694,711 - $844,255	-2,644 Reduced 10.57%	22,379 $6.99 Million
Q1 2024 Apr 19, 2024	BUY	$268.87 - $324.56 $665,184 - $802,961	2,474 Added 10.97%	25,023 $7.11 Million
Q4 2023 Jan 18, 2024	BUY	$255.7 - $288.46 $166,205 - $187,499	650 Added 2.97%	22,549 $6.49 Million
Q3 2023 Oct 23, 2023	BUY	$218.65 - $271.46 $19,241 - $23,888	88 Added 0.4%	21,899 $5.89 Million
Q2 2023 Jul 26, 2023	BUY	$214.27 - $253.37 $49,282 - $58,275	230 Added 1.07%	21,811 $4.84 Million
Q1 2023 Apr 24, 2023	BUY	$225.79 - $275.2 $43,125 - $52,563	191 Added 0.89%	21,581 $5.22 Million
Q4 2022 Jan 20, 2023	BUY	$229.03 - $291.01 $151,846 - $192,939	663 Added 3.2%	21,390 $0
Q3 2022 Oct 21, 2022	BUY	$224.46 - $253.15 $5,611 - $6,328	25 Added 0.12%	20,727 $4.67 Million
Q2 2022 Jul 22, 2022	SELL	$230.71 - $256.74 $230,940 - $256,996	-1,001 Reduced 4.61%	20,702 $5.04 Million
Q1 2022 Apr 22, 2022	SELL	$219.27 - $242.57 $164,891 - $182,412	-752 Reduced 3.35%	21,703 $5.25 Million
Q4 2021 Feb 02, 2022	BUY	$198.88 - $227.6 $88,302 - $101,054	444 Added 2.02%	22,455 $5.05 Million
Q3 2021 Nov 03, 2021	BUY	$212.27 - $248.7 $81,936 - $95,998	386 Added 1.78%	22,011 $4.68 Million
Q2 2021 Jul 29, 2021	BUY	$233.58 - $259.14 $72,409 - $80,333	310 Added 1.45%	21,625 $5.27 Million
Q1 2021 May 13, 2021	BUY	$221.91 - $258.6 $337,081 - $392,813	1,519 Added 7.67%	21,315 $5.3 Million
Q4 2020 Feb 04, 2021	SELL	$216.38 - $257.67 $38,299 - $45,607	-177 Reduced 0.89%	19,796 $4.55 Million
Q3 2020 Nov 03, 2020	SELL	$234.65 - $260.95 $55,846 - $62,106	-238 Reduced 1.18%	19,973 $5.08 Million
Q2 2020 Jul 29, 2020	BUY	$197.81 - $242.74 $9,099 - $11,166	46 Added 0.23%	20,211 $4.77 Million
Q1 2020 Apr 29, 2020	BUY	$182.24 - $241.7 $326,756 - $433,368	1,793 Added 9.76%	20,165 $4.09 Million
Q4 2019 Jan 27, 2020	BUY	$189.21 - $243.2 $28,570 - $36,723	151 Added 0.83%	18,372 $4.43 Million
Q3 2019 Nov 06, 2019	SELL	$174.11 - $208.62 $17,411 - $20,862	-100 Reduced 0.55%	18,221 $3.53 Million
Q1 2019 May 13, 2019	BUY	$180.87 - $203.88 $180 - $203	1 Added 0.01%	18,321 $3.48 Million
Q4 2018 Feb 13, 2019	BUY	$178.4 - $208.25 $35,680 - $41,650	200 Added 1.1%	18,320 $3.57 Million
Q3 2018 Nov 14, 2018	BUY	$185.29 - $208.89 $37,243 - $41,986	201 Added 1.12%	18,120 $3.76 Million
Q2 2018 Jul 27, 2018	SELL	$166.05 - $186.51 $41,512 - $46,627	-250 Reduced 1.38%	17,919 $3.31 Million
Q1 2018 Apr 20, 2018	BUY	$169.43 - $198.0 $506,595 - $592,020	2,990 Added 19.7%	18,169 $3.1 Million
Q4 2017 Feb 01, 2018	BUY	$168.79 - $188.59 $25,487 - $28,477	151 Added 1.0%	15,179 $2.64 Million
Q3 2017 Oct 11, 2017	BUY	$167.29 - $191.0 $2.51 Million - $2.87 Million	15,028	15,028 $2.8 Million

Others Institutions Holding AMGN

# of Institutions

3,125

Shares Held

409M

Call Options Held

7.56M

Put Options Held

7.2M

View Full List

About AMGEN INC

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $141B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

More about AMGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Everett Harris & CO , based on Form 13F filings with the SEC.

News

Stay updated on Everett Harris & CO with notifications on news.

Account

Everett Harris & CO Amgen Inc Transaction History